The €150 million collaboration between UK pharma GSK and Germany’s CureVac builds on their existing relationship and will jointly develop next generation mRNA vaccines. It will attempt to ...

inventory building in the US and strong demand in Germany. GSK's HIV business, run through joint venture company ViiV Healthcare, also had a good quarter with sales up 14% to £1.4 billion ...

When Hurricane Helene damaged western North Carolina in September, filling medical facilities with people who couldn't be ...

European stocks closed broadly higher on Tuesday with investors largely making cautious moves, digesting mixed earnings updates and ...

CureVac Strengthens Leadership Team with Appointment of Seasoned industry Executive Axel Sven Malkomes as Chief financial Officer ...

The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...

Big gains for defense and health stocks, but it’s a bleak day if you’re driving the green transition — or lending to Mexicans ...

Activist investor Elliott Investment Management has built up a sizable stake in RWE AG and is calling on the German utility’s ...

With a net cash position (including investments) over more than 10 years, Nabtesco has maintained a healthy balance sheet, in our view. As of fiscal 2023, net debt/EBITDA is at minus 1.1 and we expect ...

According to David Francas, PhD, professor of data and supply chain analysis at Worms University of Applied Sciences, Worms, ...

The Global Topical Drug Delivery Market Size is projected to grow at a CAGR of 6.3% from 2024 to 2031, according to a new report published by Verified Market Research ®. The report reveals that the ...